| |
|
|
|
|
|
|
|||
|
Blood, 1 October 2007, Vol. 110, No. 7, pp. 2704-2707. Prepublished online as a Blood First Edition Paper on July 6, 2007; DOI 10.1182/blood-2006-12-064154.
Brief Report Cul4A is required for hematopoietic stem-cell engraftment and self-renewal1 Herman B Wells Center for Pediatric Research, Departments of2 Pediatrics, 3 Biochemistry and Molecular Biology, and 4 Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN Several hematopoietic stem-cell (HSC) regulators are controlled by ubiquitin-mediated proteolysis, so the ubiquitin pathway might modulate HSC function. However, this hypothesis has not been formally tested. Cul4A encodes a core subunit of one ubiquitin ligase. Whereas Cul4A-deficient embryos die in utero, Cul4A-haploinsufficient mice are viable but exhibit abnormal hematopoiesis (fewer erythroid and primitive myeloid progenitors). Given these data, we examined whether Cul4A+/– HSCs might also be impaired. Using bone marrow transplantation assays, we determined that Cul4A+/– HSCs exhibit defects in engraftment and self-renewal capacity. These studies are the first to demonstrate that ubiquitin-mediated protein degradation is important for HSC function. Further, they indicate that a Cul4A ubiquitin ligase targets for degradation one or multiple HSC regulators.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||